Clinical Trial Update: The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and efficacy of 18F-Fluoromethylcholine PET/CT in prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-Fluoromethylcholine (18F-FCH) (18F-Fluoromethylcholine)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED